PEG in head and neck cancer patients - necessity, usage behavior and quality of life

PEG in head and neck cancer patients - necessity, usage behavior and quality of life - pegqol

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00027091

Enrollment

100

Registered

2021-11-05

Start date

2020-07-25

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

head and neck cancer of the upper aerodigestive tract

Interventions

Group 1: Patients with head and neck cancer who received a feeding tube complete a questionnaire on usage behavior and quality of life.

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Carcinoma of the upper aerodigestive tract, PEG, PEJ, gastrostoma, jejunostoma

Exclusion criteria

Exclusion criteria: Benign disease with dysphagia and tube feeding system.

Design outcomes

Primary

Measure	Time frame
Need for the PEG system. Time of survey: After completion of primary therapy and within the first 5 years of follow-up.	—

Secondary

Measure	Time frame
Quality of life with a PEG system	—

Countries

Germany

Contacts

Public ContactSteffen Nolte

Bundeswehrkrankenhaus UlmKlinik und Poliklinik für HNO-Heilkunde

steffennolte@bundeswehr.org073117101503

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026